Diogenx

Developer of therapeutics for the treatment of diabetes

placeMarseille, Provence Alpes Cote D Azur, France calendar_todayFounded 2019 groups9 employees language diogenx.com

Innovation

2 patent families — focus: Chemistry & metallurgy; filing pace accelerating. Cited 105 times.

YearFilings
20231
20242
20251

Investor mix

9 investors on record; lead investors include Boehringer Ingelheim Venture Fund, T1D Fund, AdBio partners.

Investor typeCountShare
Venture capital444%
Private equity111%
Accelerator & incubator111%
Other / undisclosed333%
Coming soon